DOI:
10.1055/s-00000134
Diabetologie und Stoffwechsel
LinksClose Window
References
Dandona P, Mathieu C, Phillip M. et al
Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial.
Lancet Diabetes Endocrinol 2017;
5: 864-876
DOI: 10.1016/S2213-8587(17)30308-X.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.